and recommendation
Osiris Therapeutics, Inc. (OSIR)
Osiris Therapeutics (OSIR) researches, develops, manufactures, markets, and distributes regenerative medicine products.
OSIR products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.
Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.
- September 9, 2014 - 2:36pm | Research Notes
- September 8, 2014 - 3:18pm | Model Portfolio
- August 18, 2014 - 1:48pm | Earnings
- August 13, 2014 - 8:58pm | Clear and Present Dangers
- August 3, 2014 - 10:30pm | Earnings Q2
- July 17, 2014 - 9:23am | IP & Patents
- May 29, 2014 - 8:44am | Out and About, BOD & C-Suite Updates
- May 27, 2014 - 9:14am | BOD & C-Suite Updates
- May 17, 2014 - 1:31pm | Earnings, Earnings Q1
- May 17, 2014 - 1:27pm | Earnings
- April 25, 2014 - 10:08am | BOD & C-Suite Updates
- April 21, 2014 - 2:18pm | Research Notes
- April 9, 2014 - 9:33am | Financings
- April 4, 2014 - 9:08am
- March 26, 2014 - 9:16am | BOD & C-Suite Updates
- March 11, 2014 - 10:45pm | Earnings, Earnings Q4
- March 11, 2014 - 8:44am | Earnings
- February 23, 2014 - 3:20pm
- February 10, 2014 - 10:47am | Earnings
- January 15, 2014 - 9:02am | BOD & C-Suite Updates